Click here to go back to main page.
| Stryker Corporation | |||
| Brief Description | Stryker's surgical products include such instruments as drills, saws, and even cement mixers. The company's Reconstructive division markets artificial hip and knee joints, trauma implants, bone cement, and other orthopedic supplies. The MedSurg Equipment segment houses microsurgery instruments, endoscopy equipment, and communications and patient handling tools. Stryker's Neurotechnology and Spine unit provides rods, screws, and artificial discs for spinal surgeries, as well as coils and stents for cerebral vascular procedures. The firm's products are marketed globally to hospitals, doctors, and other health care facilities via direct sales personnel and distributors. | ||
| Revenues | 2008: 6.72 billion USD | ||
| 2009: 6.72 billion USD | |||
| 2010: 7.32 billion USD | |||
| Net profit (2010) | 1.27 billion USD | ||
| R&D expenses | 2008: 367.8 million USD (5.5% of revenues) | ||
| 2009: 336.2 million USD (5.0% of revenues) | |||
| 2010: 393.9 million USD (5.4% of revenues) | |||
| Number of employees | 20,036 | ||
| Year Established | 1938 | ||
| Headquarters | 2825 Airview Blvd. Kalamazoo, MI 49002-1802, United States | ||
| Key People | Stephen MacMillan (Chairman & CEO) Curt Hartman (CFO) |
||
| Segmental revenue breakdown (2010) | Orthopedic implants: 59% MedSurg equipment: 41% |
||
| Geographical revenue breakdown (2010) | US: 65%% Rest of world: 35% |
||